| |
Prizes, Awards and Grants Programs
Recipients of Annual Awards 2006 in the field of Haematological Malignancies
The Board of Trustees of the Jacqueline Seroussi Memorial Foundation for Cancer Research noted the selection of Award Recipients as unanimously decided by the Panel. The Board unanimously agreed to act upon the Panel's selection of the following Awardees:
| (1) | Prof. Volker Diehl University of Cologne Cologne, Germany |
| (2) | Prof. Wolfgang Hiddemann University of Munich Munich, Germany |
| (3) | Prof. Alexander Levitzki The Hebrew University of Jerusalem Jerusalem, Israel |
| (4) | Prof. Bob Löwenberg Erasmus University Medical Center, Rotterdam, The Netherlands |
| (5) | Prof. Arnon Nagler Chaim Sheba Medical Center Ramat Gan, Israel |
| (6) | Prof. Rainer F. Storb Fred Hutchinson Cancer Research Center Seattle, WA, USA |
The Awards will be in the sum of US$ 150,000 each.
Recipients of Annual Awards 2005 in the field of Breast Cancer Disease
The Board of Trustees of the Jacqueline Seroussi Memorial Foundation for Cancer Research noted the selection of Award Recipients as unanimously decided by the Panel. The Board unanimously agreed to act upon the Panel's selection of the following Awardees:
| (1) | Richard D. Gelber, PhD Dana-Farber Cancer Institute Boston,USA |
| (2) | Prof. Yoav I. Henis Neurobiochemistry George S. Wise Faculty of Life Sciences Tel Aviv University Tel Aviv, Israel |
| (3) | Prof. Joseph Kost Chemical Engineering Ben Gurion University of the Negev Beer Sheva, Israel |
| (4) | C. Kent Osborne, MD Professor of Medicine & Molecular and Cell Biology Director, Breast Cancer Baylor College of Medicine Houston, USA |
| (5) | Martine Piccart, MD Chairman of BIG Chemotherapy Unit Jules Bordet Institute Brussels, Belgium |
| (6) | Prof. Umberto Veronesi Scientific Director European Institute of Oncology (EIO) Milan, Italy |
Furthermore, it was decided to give a special Award for contributing to the cause of cancer research to Dr. Salwa Boulos, Dept. of Radiology, Mammography, Ospedale Italiano Umberto I, Cairo, Egypt, for her unique breakthrough work in early diagnosis of Breast Cancer in women in Egypt.
The Awards will be in the sum of US$ 125,000 each with exception of the key-note speaker, Prof. Umberto Veronesi, who will receive US$ 150,000.
Recipients of Annual Awards 2004 in the field of oncologic diseases affecting the respiratory system
Recipients of Annual Awards 2004
The Board of Trustees of the Jacqueline Seroussi Memorial Foundation for Cancer Research noted the selection of Award Recipients as unanimously decided by the Panel. The Board unanimously agreed to act upon the final selection of the following Awardees:
| (1) | Prof. Gustav K. von Schulthess, M.D., Ph.D.
Dept. Medical Radiology
Director, Division of Nuclear Medicine
University Hospital
Zurich, Switzerland
(Awarded: US$ 150,000) |
| (2) | Prof. Frances A. Shepherd, MD, FRCPC
Scott Taylor Chair in Lung Cancer Research
Princess Margaret Hospital
University of Toronto, Canada
(Awarded: US$ 150,000) |
| (3) | Prof. Waun Ki Hong, M.D.
Head, Division of Cancer Medicine
The University of Texas
M.D. Anderson Cancer Center
Houston, Texas, USA
(Awarded: US$ 150,000) |
| (4) | Prof. Adi F. Gazdar, M.D.
University of Texas
Southwestern Medical Center
Dallas, Texas, USA
(Awarded: US$ 150,000) |
| (5) | Prof. Mia Horowitz, Ph.D.
Dept. Cell Research & Immunology
Tel Aviv University,
Ramat Aviv, Israel
(Awarded: US$ 150,000) |
| (6) | Prof. Gidi Rechavi, M.D., Ph.D.
Head, Sheba Cancer Research Center
Head, Tel Aviv University Cancer Biology Research Center
Tel Aviv, Israel
(Awarded: US$ 150,000) |
Recipients of Annual Awards 2003 in the field of malignant tumours of the gastrointestinal system
The Board of Trustees of the Jacqueline Seroussi Memorial Foundation for Cancer Research noted the selection of Award Recipients as unanimously decided by the Panel. The Board unanimously agreed to act upon the final selection of the following Awardees:
| (1) |
Prof. Henry T Lynch M.D.
Professor of Medicine and Chairman, Dept. of Preventive Medicine, Creighton University Medical Center, Omaha, Nebraska, USA
(Awarded: US$ 150,000)
|
| (2) |
Prof. Moses Judah Folkman M.D.
Professor of Pediatric Surgery, Harvard Medical School; Professor of Cell Biology, Harvard Medical School; Director, Surgical Research
Laboratory, Children's Hospital, Boston, Massachusetts, USA
(Awarded: US$ 150,000)
|
| (3) |
Prof. Gert Riethmüller M.D.
Institut für Immunologie, Chairman of Cancer Center, University München, Germany
(Awarded: US$ 150,000)
|
| (4) |
Prof. Sir Walter F. Bodmer Ph.D.
Principal, Hertford College, Oxford; Head of Laboratory Cancer
Research, UK; Cancer and Immunogenetics Laboratory,
Weatherall Institute of Molecular Medicine, Oxford, United Kingdom
(Awarded: US$ 150,000)
|
| (5) |
Prof. Isaac P. Witz Ph.D.
Department of Cell Research and Immunoglogy, Tel-Aviv University,
Tel-Aviv, Israel
(Awarded: US$ 150,000)
|
| (6) |
Yehuda Chowers M.D.
Senior Physician, Chaim Sheba Medical Center, Tel-Hashomer, Israel
(Awarded: US$ 150,000)
|
Recipients of Annual Awards 2002 in the field of malignant tumours of the neurological system
During a festive ceremony on December 5, 2002 the Foundation handed the Awards for the year 2002 to the six Recipients:
- Prof. Vincent Peter Collins, originally with the Karolinska Institute, now University of Cambridge, UK
- Prof. Monika E. Hegi, University Hospital Lausanne, Switzerland
- Prof. Eric C. Holland, Memorial Sloan Kettering Cancer Center, New York, USA
- Prof. Adi Kimchi, Weizmann Institute of Science, Rehovot, Israel
- Prof. Yoel Kloog, Tel Aviv University, Tel Aviv, Israel
- Prof. Michael Weller, University of Tübingen, Tübingen, Germany
As for the 2003 Awards, the Board of Trustees approved a budget for the Foundation in the amount of US$ 1 million, most of which will be devoted to Awards to be given to up to six meritorious individuals and/or groups who have produced and will continue to produce important work in the field of oncologic diseases affecting the digestive system. The amount of each Award will vary between a minimum of US$ 125.000 and a maximum of US$ 175.000 according to the merits of the projects selected.
The 2003 Annual Awards Ceremony will take place on Thursday December 4, 2003 in Tel Aviv, Israel.
(For further information please click on the December 2002 News Bulletin & Events)
|
Approval of the Annual Awards for the year 2002 totalling US$ 1.250.000
The Foundation is proud to announce that following a meeting in Zurich on April 19–21, 2002 of the Members of the Board of Trustees and the Advisory Panel, the selection of the following Awardees was unanimously approved:
-
Adi Kimchi from the Weizmann Institute of Science, Rehovot, Israel - for cutting edge, well-written research into brain metastases; the mechanisms for brain metastases and the development of inhibiting factors to stop metastases and invasion. ( Awarded US$ 250.000)
Yoel Kloog from Tel-Aviv University, Tel-Aviv, Israel - working on many tumors and especially on a novel approach to glioma treatment by specific inhibition of ras signalling. (Awarded US$ 250.000)
Vincent Collins, originally with the Karolinska Institute, now in Cambridge, United Kingdom. A well-recognized authority who continues to do important work on genetic and expression profiling of gliomas and their clinical relevance. He has had a major impact on modern neuropathology. (Awarded US$ 250.000)
Dr. Eric Holland, from Memorial-Sloan Kettering Cancer Institute, New York, U.S.A. He was formerly a clinician neurosurgeon who is now devoted to research. His area of concentration is on the use of retroviral vectors for the development of animal brain tumor models. (Awarded US$ 200.000)
Dr. Michael Weller, from the Department of Neurology, University of Tübingen, Tübingen, Germany. For novel approaches to molecular therapy of gliomas by targeting and activating the p53 controlled death-signalling pathway. (Awarded US$ 150.000)
Dr. Monika Hegi, from the Laboratory of Tumor Biology and Genetics, Lausanne, Switzerland. For profiling of human gliomas for tumor classification by gene expression, and identification of predictive factors. (Awarded US$ 150.000)
|
Annual Awards to Researchers for the Year 2002
in honor of Jacqueline Seroussi
1. Annual Awards Ceremony
A festive first ceremony for granting the Foundation’s annual awards in honor of Jacqueline Seroussi, will be held on July 3, 2002, in Tel Aviv / Israel (for details please click “News Bulletin & Events”).
2. Timetable The timetable leading to such event, taking into account that ample notice should be given to winners and guests, particularly those arriving from abroad, is essentially the following:
2.1 A Committee of 3 Trustees has already been appointed by the Board. This committee shall propose the individuals and/or teams of researchers to a Panel of 6 experts (3 International and 3 Israeli) as from October 1, 2001 and not later than March 1, 2002.
2.2 The candidates proposed shall consist of 12 researchers (individuals and/or teams) whose efforts, for the first annual awards, are directed to the research of malignant tumours of the neurological system.
2.3 The selection of the winners will be made not later than May 1, 2002. The winners shall be selected for their outstanding accomplishments as well as their past, present and ongoing extraordinary contributions to cancer research mentioned in 2.2 above.
3. Total Amount of Awards and Number of Winners The total amount of the awards that shall be distributed on July 3, 2002, is US$ 1.250.000. Forty percent (40%), i.e. US$ 500.000, shall be exclusively reserved for two (2) Israeli individuals and/or research teams. This sum shall not necessarily be awarded on the basis of an equal split. The percentage for each individual and/or research team may vary and shall be fixed by the Board, with the proviso that a single individual/team shall not receive more than 70% of the sum allocated. The balance of sixty percent (60%), i.e. US$ 750.000, shall be awarded to a minimum of two (2) and a maximum of three (3) international individuals and/or research teams in which any qualified Israeli individual and/or team can also participate. Likewise, the allocation of the awards shall not necessarily be on the basis of an equal split. The percentage for each individual and/or team may vary and shall be fixed by the Board, with the proviso that a single individual and/or team shall not receive more than 50% of the sum allocated.
4. Future Awards The Foundation’s annual awards budget for the year 2003 will be fixed by the Board during its meeting next year. Full details will appear on this site.
|